Chinese manufacturing activity contracted this month to its weakest rate in eight months, data showed yesterday, the latest indication of slowing growth in the world’s No. 2 economy.
The data is the latest in a string of weak indicators out of Beijing, with analysts suggesting the Chinese government could announce a series of measures to inject life back into the Asian powerhouse.
HSBC’s preliminary purchasing managers’ index (PMI), which tracks manufacturing activity in China’s factories and workshops, fell to 48.1 from a final reading of 48.5 last month, the British bank said in a statement.
The figure is down from 49.5 in January and was the worst result since July last year’s 47.7, the bank said.
The final figure is due out on April 1.
The index is a closely watched gauge of the health of the Asian economic powerhouse and key driver of global growth. A reading above 50 indicates growth, while anything below signals contraction.
The Chinese National Bureau of Statistics said earlier this month that its own official PMI reading fell to an eight-month low of 50.2 last month.
The latest figure “suggests that China’s growth momentum continued to slow down” this month, Hong Kong-based HSBC chief China economist Qu Hongbin (屈宏斌) said in the statement.
“Weakness is broadly based with domestic demand softening further,” he added.
HSBC expects Chinese authorities to take policy steps to stabilize the Chinese economy, with actions including easing barriers to private investment, spending on urban railways, public housing and fighting air pollution, as well as “guiding lending rates lower,” Qu said.
Other economists also expressed concerns, saying that this month’s figure usually benefits from a cyclical boost.
“The weakness appears even more pronounced given that there is usually a seasonal rebound after the Chinese New Year holiday,” Capital Economics Asia economist Julian Evans-Pritchard said in research note.
China’s annual Lunar New Year holiday fell in February this year.
A snap Agence France-Presse poll of economists earlier this month predicted a median forecast of 7.4 percent economic growth in China this year.
The government this month set its annual growth target at 7.5 percent, the same as that set last year.
If the actual result comes in below, it would be the first time in 16 years that the objective had not been reached.
The economy grew 7.7 percent last year, the same as in 2012 — which was the slowest rate since 1999.
“The government needs to take quick action in view of its growth target of about 7.5 percent,” Barclays Capital said in an analysis of the PMI data.
Hong Kong-based Nomura International economist Zhang Zhiwei (張智威) said he expects leaders to cut the amount of funds banks must keep in reserve in the second half of the year — a step they have used in the past to boost liquidity.
He also expects fiscal policy to turn “expansionary” in the second quarter to prevent GDP growth from falling below 7 percent.
However, Evans-Pritchard said authorities were unlikely to take significant stimulatory action.
“Today’s weak PMI reading is the latest sign that slowing credit and investment growth are weighing on domestic demand,” he wrote. “That said, with no sign of stress in the labor market, the slowdown does not yet appear to warrant a significant stimulus response.”
Gogoro Inc (睿能創意) yesterday launched its first electric bicycle, the Gogoro Eeyo 1, in Taiwan, after unveiling the bike in New York in late May and in France on Tuesday. The company said it would also introduce the series in other European countries such as Germany and the Netherlands. The “Eeyo project” is the fourth of Gogoro’s eight projects that concentrate on smart transportation, which includes Gogoro’s electric scooter, battery swap system and electric scooter sharing service, company founder and chief executive officer Horace Luke (陸學森) told a media briefing in Taipei. “There are various types of city commuters. We will not
EXPERIMENTAL DRUG: While news about a COVID-19 vaccine is more eye-catching, developing a treatment would be more viable, the Senhwa boss said Senhwa Biosciences Inc (生華科) aims to raise NT$1.5 billion (US$50.57 million) by issuing 15 million new common shares in the third quarter of this year to fund the research of new drugs, including the experimental drug Silmitasertib for the treatment of COVID-19, the company said on Monday. That would be the firm’s largest fundraising effort after it raised more than NT$1.4 billion from an initial public offering on the Taipei Exchange (TPEX) in April 2017, chief financial officer Sarah Chang (張小萍) told the Taipei Times by telephone. The price of the new shares would depend on the firm’s average share price
NOT A PANACEA: Offering 5G services would not solve the problem of declining telecom incomes, chairman Sheih Chi-mau said, expecting a flat 5G telecom revenue Chunghwa Telecom Co (中華電信) yesterday became the nation’s first telecom to debut its 5G services, offering tiered tariffs that include a threshold of NT$599 and flat rates, as it aims to switch half of its subscribers to the 5G network within three years. Subscribers would have unlimited data transmission for monthly fees starting at NT$1,399 — the same flat rate as when the company launched its 4G service in 2014 — and they can subscribe to the highest-rate plan for NT$2,699 per month for faster data transmission speeds and larger bandwidth, the company said. Data transmission speeds would be within the range
STAYING AHEAD: TSMC expects its sales this year to grow 14 to 19 percent and could spend up to US$3.52 billion on research and development, leaving its rivals far behind Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) reported that the US last year approved 99 percent of its patent applications, which placed the tech giant among the top patent holders in the US. In its Corporate Social Responsibility Report, TSMC said it last year secured about 3,600 patents worldwide, including more than 2,300 in the US. As of the end of last year, TSMC owned more than 39,000 patents, the report said. The company last year filed almost 6,500 patent applications worldwide and ranked among the top 10 patent applicants in the US. In Taiwan, it was the largest patent applicant for the fourth